scholarly journals Phase I Safety, Pharmacokinetic and Pharmacodynamic Evaluation of the Vascular Disrupting Agent Ombrabulin (AVE8062) in Patients with Advanced Solid Tumors

2013 ◽  
Vol 19 (17) ◽  
pp. 4832-4842 ◽  
Author(s):  
Cristiana Sessa ◽  
Patricia Lorusso ◽  
Anthony Tolcher ◽  
Françoise Farace ◽  
Nathalie Lassau ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
Vascular Disrupting Agent ◽  
Vascular Disrupting

A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors

2011 ◽  
Vol 68 (4) ◽  
pp. 959-970 ◽  
Author(s):  
Alejandro D. Ricart ◽  
Edward A. Ashton ◽  
Matthew M. Cooney ◽  
John Sarantopoulos ◽  
Joanna M. Brell ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors ◽  
Vascular Disrupting Agent ◽  
Vascular Disrupting

scholarly journals Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors

2016 ◽  
Vol 48 (1) ◽  
pp. 28-36 ◽  
Author(s):  
Do-Youn Oh ◽  
Tae-Min Kim ◽  
Sae-Won Han ◽  
Dong-Yeop Shin ◽  
Yun Gyoo Lee ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors ◽  
Vascular Disrupting Agent ◽  
Vascular Disrupting

Phase I Clinical and Pharmacokinetic Evaluation of the Vascular-Disrupting Agent OXi4503 in Patients with Advanced Solid Tumors

2012 ◽  
Vol 18 (5) ◽  
pp. 1415-1425 ◽  
Author(s):  
Dan M. Patterson ◽  
Martin Zweifel ◽  
Mark R. Middleton ◽  
Patricia M. Price ◽  
Lisa K. Folkes ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
Vascular Disrupting Agent ◽  
Vascular Disrupting ◽  
Pharmacokinetic Evaluation

Phase I pharmacokinetic and pharmacodynamic evaluation of the vascular disrupting agent OXi4503 in patients with advanced solid tumors.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 2594-2594 ◽  
Author(s):  
M. Zweifel ◽  
D. M. Patterson ◽  
A. R. Padhani ◽  
M. R. Middleton ◽  
P. Price ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
Vascular Disrupting Agent ◽  
Vascular Disrupting

scholarly journals Phase I and pharmacokinetic study of the vascular‐disrupting agent CKD‐516 (NOV120401) in patients with refractory solid tumors

2020 ◽  
Vol 8 (2) ◽  
Author(s):  
Hark Kyun Kim ◽  
Jeong Won Kang ◽  
Young‐Whan Park ◽  
Jung Young Kim ◽  
Minchae Kim ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pharmacokinetic Study ◽  
Vascular Disrupting Agent ◽  
Vascular Disrupting
Sign in / Sign up

Export Citation Format

Share Document